Welcome back to the forum. I have been dealing with some neuropathy-like symptoms recently and have seen several doctors, had MRI, bloodwork and physical exams and have not found a cause, though I suspect it is autoimmune related. Tremors, numb extremities/face, painful teeth/genitals. I have done exhaustive internet searches and found the most comprehensive retrospective study regarding neuropathy and IBD below. There seems to be a link between the two but it is not well understood. You'll need to read the whole study but my conclusions from my own research and from the link below are as follows:
Men with IBD are much more likely to suffer from neuropathy than women with IBD.
Give or take, about
30% of all Americans will suffer from neuropathy in their lifetime. Approximately 30% of these people will be diabetic, 30% will have idiopathic neuropathy (no known cause), and about
30% will have some other underlying condition whether autoimmune, alcoholism, injury, malignancy etc.
Interestingly, the authors of the case series below state that immuno-modulators (azathioprene/imuran) are the most effective drugs in dealing with neuropathy in the context of IBD. I can't comment on your specific sutuation, I have no personal experience with immunomodulators. My doctor started me on generic cymbalta, off-label. It has taken the edge off at a low dose but has not been a cure-all. It has also come with several side effects that seem to be getting better as I adjust to the drug. If my condition worsens I will ask for imuran because I cannot afford to be disabled in my line of work. I'm only 37. They are ordering more comprehensive bloodwork for me as we speak. If you find anything out I'd be very interested. Good luck!
See below:
/academic.oup.com/brain/article/128/4/867/284345/Peripheral-neuropathy-in-patients-with"Conclusions
This study presents the largest case series of PN in IBD. Despite the intrinsic limitations of any retrospective study (referral bias leading to complex epidemiological patterns, unblinded ascertainment of individual response to therapy) and considering that our patients were seen in a tertiary centre after multiple evaluations at different centres, the aid of an extensive, systematic, combined analysis of the literature enabled us to characterize the clinical and electrodiagnostic features of PN in patients with IBD. These clinical syndromes are diverse and most likely secondary to PN ascertainment at different stages of IBD evolution, but certainly include a high percentage of acquired demyelinating PN. In IBD, response to immunotherapy occurred as expected in demyelinating PN, but also in patients with nerve conduction studies and neuropathological findings characteristic of an axonal neuropathy. Therefore, despite the fact that our study is retrospective and not designed to establish causality between IBD and PN, it is likely that there is a primary immune-mediated neuropathy as an extra-intestinal disorder associated with IBD and not merely a co-occurrence with CIDP. Overall, men with IBD may be more susceptible to the development of PN than women. However, women may be more prone to demyelinating neuropathies."